Barclays
CGEN icon

Barclays’s Compugen CGEN Stock Holding History

Barclays’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-560
Closed -$857 – 5292
2024
Q4 		$857 Hold
560
– – ﹤0.01% 5146
2024
Q3 		$1.01K Hold
560
– – ﹤0.01% 5126
2024
Q2 		$941 Sell
560
-737
-57% -$1.53K ﹤0.01% 4687
2024
Q1 		$3.35K Hold
1,297
– – ﹤0.01% 4887
2023
Q4 		$2.57K Buy
1,297
+703
+118% +$614 ﹤0.01% 5064
2023
Q3 		$552 Buy
594
+297
+100% +$327 ﹤0.01% 4508
2023
Q2 		$338 Sell
297
-1,000
-77% -$872 ﹤0.01% 4399
2023
Q1 		$911 Hold
1,297
– – ﹤0.01% 4932
2022
Q4 		$929 Sell
1,297
-5,676
-81% -$4.95K ﹤0.01% 5126
2022
Q3 		$5K Sell
6,973
-15,225
-69% -$21.5K ﹤0.01% 4490
2022
Q2 		$41K Buy
22,198
+20,198
+1,010% +$43.6K ﹤0.01% 4106
2022
Q1 		$6K Sell
2,000
-94
-4% -$317 ﹤0.01% 4671
2021
Q4 		$9K Sell
2,094
-11,468
-85% -$62K ﹤0.01% 3996
2021
Q3 		$80K Buy
13,562
+5,024
+59% +$33.7K ﹤0.01% 3981
2021
Q2 		$71K Sell
8,538
-8,668
-50% -$70.4K ﹤0.01% 3971
2021
Q1 		$147K Sell
17,206
-30,060
-64% -$333K ﹤0.01% 3844
2020
Q4 		$572K Sell
47,266
-3,850
-8% -$53.1K ﹤0.01% 3164
2020
Q3 		$831K Buy
51,116
+1,216
+2% +$19.9K ﹤0.01% 2847
2020
Q2 		$749K Buy
49,900
+32,700
+190% +$441K ﹤0.01% 3007
2020
Q1 		$125K Buy
17,200
+17,046
+11,069% +$134K ﹤0.01% 4639
2019
Q4 		$1K Buy
+154
New +$792 ﹤0.01% 6269
2019
Q2 		– Sell
-42
Closed – – 6958
2019
Q1 		$0 Sell
42
-428
-91% -$1.47K ﹤0.01% 7035
2018
Q4 		$1K Buy
470
+428
+1,019% +$1.36K ﹤0.01% 6778
2018
Q3 		$0 Hold
42
– – ﹤0.01% 7145
2018
Q2 		$0 Sell
42
-15,465
-100% -$58.1K ﹤0.01% 6991
2018
Q1 		$69K Buy
15,507
+15,400
+14,393% +$51.9K ﹤0.01% 5645
2017
Q4 		$0 Buy
+107
New +$318 ﹤0.01% 6937
2017
Q3 		– Sell
-367
Closed -$1K – 6853
2017
Q2 		$1K Buy
367
+114
+45% +$474 ﹤0.01% 6491
2017
Q1 		$1K Sell
253
-1,499
-86% -$6.92K ﹤0.01% 6554
2016
Q4 		$9K Sell
1,752
-378
-18% -$2.26K ﹤0.01% 5926
2016
Q3 		$13K Buy
2,130
+1,392
+189% +$9.42K ﹤0.01% 5666
2016
Q2 		$4K Buy
738
+290
+65% +$1.94K ﹤0.01% 5778
2016
Q1 		$2K Sell
448
-15,173
-97% -$79.2K ﹤0.01% 5852
2015
Q4 		$93K Sell
15,621
-12,683
-45% -$83.2K ﹤0.01% 4440
2015
Q3 		$141K Buy
28,304
+17,718
+167% +$103K ﹤0.01% 4386
2015
Q2 		$63K Buy
10,586
+8,270
+357% +$57.9K ﹤0.01% 5002
2015
Q1 		$16K Buy
2,316
+2,116
+1,058% +$17.3K ﹤0.01% 5938
2014
Q4 		$2K Buy
+200
New +$1.54K ﹤0.01% 7116
2014
Q2 		– Sell
-95
Closed -$1K – 7612
2014
Q1 		$1K Buy
+95
New +$1.05K ﹤0.01% 7460

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Barclays's CGEN Position: Q1 2025 in Review

Barclays sold out of Compugen (CGEN) in Q1 2025, closing a stake of 560 shares — an estimated $857 sold.

Barclays first reported a position in CGEN in Q1 2014 and held it in 39 quarters. The position peaked at $831K in Q3 2020. 71 funds tracked by Wall St. Rank hold CGEN as of Q1 2025.

  • Barclays reported no remaining Compugen position as of Q1 2025 after selling out during the quarter.
  • Barclays sold 560 Compugen shares in Q1 2025, an estimated $857.
  • Barclays first reported a position in Compugen in Q1 2014 and held it in 39 quarters.
  • Barclays's Compugen position peaked at $831K in Q3 2020.
  • 71 funds tracked by Wall St. Rank held Compugen as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.